| DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors Y Jiao, C Shi, BH Edil, RF De Wilde, DS Klimstra, A Maitra, RD Schulick, ... Science 331 (6021), 1199-1203, 2011 | 1877 | 2011 |
| Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm BJ Longley, L Tyrrell, SZ Lu, YS Ma, K Langley, T Ding, T Duffy, P Jacobs, ... Nature genetics 12 (3), 312-314, 1996 | 716 | 1996 |
| HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for … AN Bartley, MK Washington, CB Ventura, N Ismaila, C Colasacco, ... American journal of clinical pathology 146 (6), 647-669, 2016 | 574 | 2016 |
| Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors S Yachida, E Vakiani, CM White, Y Zhong, T Saunders, R Morgan, ... The American journal of surgical pathology 36 (2), 173-184, 2012 | 555 | 2012 |
| The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly … O Basturk, Z Yang, LH Tang, RH Hruban, V Adsay, CM McCall, ... The American journal of surgical pathology 39 (5), 683-690, 2015 | 508 | 2015 |
| Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic … LH Tang, H Aydin, MF Brennan, DS Klimstra The American journal of surgical pathology 29 (4), 512-519, 2005 | 491 | 2005 |
| Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ... Nature 618 (7963), 144-150, 2023 | 466 | 2023 |
| Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set DS Klimstra, IR Modlin, NV Adsay, R Chetty, V Deshpande, M Gönen, ... The American journal of surgical pathology 34 (3), 300-313, 2010 | 463 | 2010 |
| Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades JM Winter, MF Brennan, LH Tang, MI D’Angelica, RP DeMatteo, Y Fong, ... Annals of surgical oncology 19, 169-175, 2012 | 391 | 2012 |
| Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis YY Janjigian, D Werner, C Pauligk, K Steinmetz, DP Kelsen, E Jäger, ... Annals of oncology 23 (10), 2656-2662, 2012 | 390 | 2012 |
| A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of … LH Tang, O Basturk, JJ Sue, DS Klimstra The American journal of surgical pathology 40 (9), 1192-1202, 2016 | 386 | 2016 |
| Small-cell carcinomas of the gastrointestinal tract: a review B Brenner, LH Tang, DS Klimstra, DP Kelsen Journal of Clinical Oncology 22 (13), 2730-2739, 2004 | 384 | 2004 |
| Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic … Z Yang, LH Tang, DS Klimstra The American journal of surgical pathology 35 (6), 853-860, 2011 | 373 | 2011 |
| Negative regulation of tumor suppressor p53 by microRNA miR-504 W Hu, CS Chan, R Wu, C Zhang, Y Sun, JS Song, LH Tang, AJ Levine, ... Molecular cell 38 (5), 689-699, 2010 | 371 | 2010 |
| Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix LH Tang, J Shia, RA Soslow, D Dhall, WD Wong, E O'Reilly, J Qin, P Paty, ... The American journal of surgical pathology 32 (10), 1429-1443, 2008 | 368 | 2008 |
| Molecular classification of gastric cancer: a new paradigm MA Shah, R Khanin, L Tang, YY Janjigian, DS Klimstra, H Gerdes, ... Clinical cancer research 17 (9), 2693-2701, 2011 | 364 | 2011 |
| PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue W Eck, G Craig, A Sigdel, G Ritter, LJ Old, L Tang, MF Brennan, PJ Allen, ... ACS nano 2 (11), 2263-2272, 2008 | 342 | 2008 |
| Genetic predictors of response to systemic therapy in esophagogastric cancer YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, ... Cancer discovery 8 (1), 49-58, 2018 | 337 | 2018 |
| Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas LH Tang, BR Untch, DL Reidy, E O'Reilly, D Dhall, L Jih, O Basturk, ... Clinical Cancer Research 22 (4), 1011-1017, 2016 | 336 | 2016 |
| Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods LH Tang, M Gonen, C Hedvat, IM Modlin, DS Klimstra The American journal of surgical pathology 36 (12), 1761-1770, 2012 | 327 | 2012 |
